POLICY Magazine
FEATURE: The Case for a Regulated Drugs Market
Robert E. Marks |
03 March 1991
Social costs of prohibiting drugs far outweigh the social benefits, and supports the Cleeland Report's (1989) recommendation of a regulated drugs market.
